32 Biosciences
Develops novel therapeutic antibodies for oncology and autoimmune diseases.
About
32 Biosciences pioneers gut mucosal-immune science to prevent and treat gastrointestinal diseases. Their GI Discovery Platform measures metabolomic signatures to enable therapeutic discovery, and their CS Therapeutic Platform develops Mucosal Immune Modulator (MIM) therapeutics that restore and protect the gastrointestinal mucosal-immune barrier. They focus on preventing and treating GI diseases with novel therapeutics. Teams look it up for Biotech, Drug Discovery, Oncology.
Frequently asked
What does 32 Biosciences do?
32 Biosciences is a Biotech company that offers Services. Teams look it up for Drug Discovery, Oncology, Autoimmune Diseases. It is based in San Diego, United States and was founded in 2017. Public records show about 9 people and $12M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has 32 Biosciences raised?
32 Biosciences has raised a total of $12M in funding.
Where is 32 Biosciences headquartered?
32 Biosciences is headquartered in San Diego, United States.
When was 32 Biosciences founded?
32 Biosciences was founded in 2017.
What industry does 32 Biosciences operate in?
32 Biosciences operates in Biotech, Drug Discovery, Oncology, Autoimmune Diseases, Therapeutic Antibodies.
How many employees does 32 Biosciences have?
32 Biosciences has approximately 9 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.